Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Mr. Kevin F. McLaughlinIndependent Director | -7,00k | 174,90k | Derivative Exercise and Sale | 2,63 - 32,83 | 18,30k | - |
| 2026-05-11 | Dr. Paul Kevin WottonIndependent Director | -10,00k | 327,43k | Verkauf | 32,64 - 33,05 | 18,80k | -34,72% |
| 2026-05-07 | Mr. Joseph Anthony MaraCFO & Treasurer | -5,00k | 202,50k | Automatic Disposition | 40,50 | 21,01k | -19,22% |
| 2026-05-06 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | -4,86k | 188,05k | Automatic Disposition | 38,00 - 40,50 | 1,12k | -81,28% |
| 2026-04-29 | Ms. Lisa WrightIndependent Director | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 15,85k | 25,29% |
| 2026-04-29 | Dr. Paul Kevin WottonIndependent Director | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 28,80k | 12,50% |
| 2026-04-29 | Mr. Alan L. RubinoIndependent Director | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 64,19k | 5,25% |
| 2026-04-29 | Dr. Robert L. ZerbeIndependent Chairman & Lead Director | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 33,00k | 10,74% |
| 2026-04-29 | Ms. Heidi M. HagenIndependent Director | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 35,05k | 10,05% |
| 2026-04-29 | Mr. Kevin F. McLaughlinIndependent Director | 3,20k | 0,00 | Derivative Exercise and Retained Stock | - | 18,30k | 21,19% |
| 2026-04-02 | Dr. Jonathan M. HopperChief Medical Officer | -3,47k | 83,50k | Derivative Exercise and Sale | 10,95 - 35,00 | 75,56k | - |
| 2026-03-25 | Mr. Alan L. RubinoIndependent Director | 15,00k | 41,40k | Derivative Exercise and Retained Stock | 2,76 | 60,99k | 32,61% |
| 2026-03-23 | Ms. Heidi M. HagenIndependent Director | -15,00k | 444,75k | Derivative Exercise and Sale | 2,76 - 32,41 | 31,85k | - |
| 2026-03-02 | Mr. Sean C. FlynnChief Legal Officer | -15,00k | 286,65k | Derivative Exercise and Sale | 16,25 - 35,36 | 1,26k | - |
| 2026-03-02 | Mr. Sean C. FlynnChief Legal Officer | -6,42k | 223,13k | Automatic Disposition | 34,75 | 1,26k | -83,57% |
| 2026-03-02 | Mr. Michael HalpinCOO | -10,31k | 363,77k | Automatic Disposition | 35,30 | 16,08k | -39,06% |
| 2026-02-24 | Mr. Sean C. FlynnChief Legal Officer | 3,62k | 0,00 | Derivative Exercise and Retained Stock | - | 7,68k | 88,91% |
| 2026-02-24 | Mr. Sean C. FlynnChief Legal Officer | -2,88k | 110,06k | Derivative Exercise and Sale | 38,09 - 38,25 | 7,68k | - |
| 2026-02-24 | Mr. Michael HalpinCOO | 5,53k | 0,00 | Derivative Exercise and Retained Stock | - | 26,39k | 26,50% |
| 2026-02-24 | Mr. Michael HalpinCOO | -4,97k | 189,78k | Derivative Exercise and Sale | 38,09 - 38,25 | 26,39k | - |
| 2026-02-24 | Dr. Jonathan M. HopperChief Medical Officer | 4,53k | 0,00 | Derivative Exercise and Retained Stock | - | 75,56k | 6,38% |
| 2026-02-24 | Dr. Jonathan M. HopperChief Medical Officer | -1,97k | 75,18k | Derivative Exercise and Sale | 38,09 - 38,25 | 75,56k | - |
| 2026-02-24 | Mr. Dominick C. ColangeloCEO, President & Director | 27,68k | 0,00 | Derivative Exercise and Retained Stock | - | 312,45k | 9,72% |
| 2026-02-24 | Mr. Dominick C. ColangeloCEO, President & Director | -8,82k | 336,11k | Derivative Exercise and Sale | 38,09 | 312,45k | - |
| 2026-02-24 | Mr. Joseph Anthony MaraCFO & Treasurer | 6,53k | 0,00 | Derivative Exercise and Retained Stock | - | 25,90k | 33,73% |
| 2026-02-24 | Mr. Joseph Anthony MaraCFO & Treasurer | -2,72k | 103,67k | Derivative Exercise and Sale | 38,09 - 38,25 | 25,90k | - |
| 2026-02-24 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | 2,05k | 0,00 | Derivative Exercise and Retained Stock | - | 5,85k | 53,99% |
| 2026-02-24 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | -1,37k | 52,11k | Derivative Exercise and Sale | 38,09 - 38,25 | 5,85k | - |
| 2026-02-18 | Mr. Joseph Anthony MaraCFO & Treasurer | 5,07k | 0,00 | Derivative Exercise and Retained Stock | - | 19,37k | 35,42% |
| 2026-02-18 | Mr. Joseph Anthony MaraCFO & Treasurer | -2,31k | 85,68k | Derivative Exercise and Sale | 36,82 - 37,41 | 19,37k | - |
| 2026-02-18 | Mr. Michael HalpinCOO | 4,78k | 0,00 | Derivative Exercise and Retained Stock | - | 20,86k | 29,71% |
| 2026-02-18 | Mr. Michael HalpinCOO | -4,30k | 159,32k | Derivative Exercise and Sale | 36,82 - 37,41 | 20,86k | - |
| 2026-02-18 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | 1,62k | 0,00 | Derivative Exercise and Retained Stock | - | 3,80k | 74,01% |
| 2026-02-18 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | -1,31k | 48,16k | Derivative Exercise and Sale | 36,82 - 37,41 | 3,80k | - |
| 2026-02-18 | Dr. Jonathan M. HopperChief Medical Officer | 4,34k | 0,00 | Derivative Exercise and Retained Stock | - | 71,03k | 6,51% |
| 2026-02-18 | Dr. Jonathan M. HopperChief Medical Officer | -982,00 | 36,74k | Derivative Exercise and Sale | 37,41 | 71,03k | - |
| 2026-02-18 | Mr. Sean C. FlynnChief Legal Officer | 2,81k | 0,00 | Derivative Exercise and Retained Stock | - | 4,07k | 222,27% |
| 2026-02-18 | Mr. Sean C. FlynnChief Legal Officer | -2,52k | 93,39k | Derivative Exercise and Sale | 36,82 - 37,41 | 4,07k | - |
| 2026-02-18 | Mr. Dominick C. ColangeloCEO, President & Director | 24,29k | 0,00 | Derivative Exercise and Retained Stock | - | 284,77k | 9,33% |
| 2026-02-18 | Mr. Dominick C. ColangeloCEO, President & Director | -5,66k | 211,63k | Derivative Exercise and Sale | 37,41 | 284,77k | - |
| 2026-02-11 | Mr. Kevin F. McLaughlinIndependent Director | -7,00k | 224,21k | Derivative Exercise and Sale | 2,63 - 34,66 | 15,10k | - |
| 2026-01-07 | Mr. Michael HalpinCOO | -10,00k | 238,20k | Derivative Exercise and Sale | 16,66 - 40,48 | 16,08k | - |
| 2025-07-22 | Ms. Karen MahoneyChief HR Officer | 1,85k | 0,00 | Derivative Exercise and Retained Stock | - | 1,85k | - |
| 2025-07-22 | Ms. Karen MahoneyChief HR Officer | -771,00 | 29,28k | Derivative Exercise and Sale | 37,98 | 1,85k | - |
| 2025-12-02 | Dr. Jonathan M. HopperChief Medical Officer | -1,65k | 34,92k | Derivative Exercise and Sale | 18,00 - 39,14 | 66,56k | - |
| 2025-12-02 | Dr. Paul Kevin WottonIndependent Director | -5,00k | 189,50k | Verkauf | 37,83 - 37,97 | 25,60k | -16,34% |
| 2025-11-11 | Mr. Michael HalpinCOO | -2,64k | 62,75k | Derivative Exercise and Sale | 16,66 - 40,41 | 15,93k | - |
| 2025-11-10 | Mr. Kevin F. McLaughlinIndependent Director | -7,00k | 251,72k | Derivative Exercise and Sale | 2,63 - 38,59 | 15,10k | - |
| 2025-11-06 | Mr. Michael HalpinCOO | -7,36k | 175,19k | Derivative Exercise and Sale | 16,66 - 40,47 | 15,93k | - |
| 2025-09-30 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | 568,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,07k | 37,82% |
| 2025-09-30 | Mr. Jonathan D. SiegalPrincipal Accounting Officer, VP & Corporate Controller | -370,00 | 11,64k | Derivative Exercise and Sale | 31,47 | 2,07k | - |
| 2025-09-02 | Dr. Jonathan M. HopperChief Medical Officer | -10,00k | 177,70k | Derivative Exercise and Sale | 18,00 - 35,77 | 66,36k | - |
| 2025-08-06 | Mr. Kevin F. McLaughlinIndependent Director | -7,00k | 232,12k | Derivative Exercise and Sale | 2,76 - 35,92 | 15,10k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
